Figure 2

(A) The effect of prolonging the duration of dual antiplatelet therapy to more than 12 months on frequency of definite or probable stent thrombosis in patients after drug-eluting stent implantation. (B) The effect of shortening the duration of dual antiplatelet therapy to less than 12 months on the frequency of definite or probable stent thrombosis in patients after drug-eluting stent implantation.